Related Experiment Videos

Emerging molecular approaches to pain therapy

M Williams¹, E A Kowaluk, S P Arneric

¹Pharmaceutical Products Division, Abbott Laboratories, DuPont Pharmaceuticals, Illinois, USA. mike.williams@abbott.com

Journal of Medicinal Chemistry

|May 7, 1999

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Adenosine modulation: a novel approach to analgesia and inflammation.

Expert opinion on investigational drugs·2005

Pyridopyrimidine analogues as novel adenosine kinase inhibitors.

Bioorganic & medicinal chemistry letters·2001

A-134974: a novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats.

Brain research·2001

Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor..

Journal of medicinal chemistry·2001

The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury.

British journal of pharmacology·2001

Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis.

The Journal of pharmacology and experimental therapeutics·2001

See all related articles